CNTX vs. NVDA

Last updated Aug 1, 2026

CNTX (Context Therapeutics Inc.) and NVDA (NVIDIA Corporation) are both stocks. CNTX operates in Biotechnology (Healthcare), while NVDA operates in Semiconductors (Technology). Over the past 3 years, CNTX returned -20.21%/yr vs 62.93%/yr for NVDA. Their 0.14 correlation means their historical movements had little consistent relationship.

Performance

CNTX vs. NVDA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Context Therapeutics Inc. (CNTX) and NVIDIA Corporation (NVDA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CNTX achieves a -59.22% return, which is significantly lower than NVDA's 7.77% return.

CNTX

• 1D: -1.30%
• 1M: -8.31%
• 6M: -77.03%
• YTD: -59.22%
• 1Y: -15.58%
• 3Y*: -20.21%
• 5Y*: —
• 10Y*: —
• ALL TIME*: -34.24%

NVDA

• 1D: 2.93%
• 1M: 3.04%
• 6M: 5.16%
• YTD: 7.77%
• 1Y: 15.71%
• 3Y*: 62.93%
• 5Y*: 59.52%
• 10Y*: 64.62%
• ALL TIME*: 36.28%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
CNTX Context Therapeutics Inc.	$892.77K	$1.46M	$1.95M
NVDA NVIDIA Corporation	$25.46B	$26.13B	$31.85B

CNTX vs. NVDA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
CNTX Context Therapeutics Inc.	-59.22%	40.00%	-7.08%	73.39%	-75.50%	-40.09%
NVDA NVIDIA Corporation	7.77%	38.92%	171.25%	239.02%	-50.26%	31.96%

Correlation

The correlation between CNTX and NVDA is 0.08, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.08
Correlation (3Y) Balances recent behavior with more history.	0.12
Correlation (All Time) Calculated using the full available price history since Oct 20, 2021	0.14

Fundamentals

Market Cap CNTX : $55.07M NVDA : $4.86T
EPS CNTX : -$0.43 NVDA : $6.53
PB Ratio CNTX : 1.09 NVDA : 25.05
Total Revenue (TTM) CNTX : $0.00 NVDA : $253.49B
Gross Profit (TTM) CNTX : -$36.34K NVDA : $187.95B
EBITDA (TTM) CNTX : -$42.56M NVDA : $192.76B

Return for Risk

CNTX vs. NVDA — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

CNTX

CNTX Risk / Return Rank: 41
CNTX Sharpe Ratio Rank: 36
CNTX Sortino Ratio Rank: 47
CNTX Omega Ratio Rank: 48
CNTX Calmar Ratio Rank: 37
CNTX Martin Ratio Rank: 35

NVDA

NVDA Risk / Return Rank: 56
NVDA Sharpe Ratio Rank: 58
NVDA Sortino Ratio Rank: 53
NVDA Omega Ratio Rank: 51
NVDA Calmar Ratio Rank: 60
NVDA Martin Ratio Rank: 59

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

CNTX vs. NVDA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Context Therapeutics Inc. (CNTX) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CNTX	NVDA	Difference
Sharpe ratio: Return per unit of total volatility	-0.18	0.36	-0.54
Sortino ratio: Return per unit of downside risk	0.51	0.76	-0.24
Omega ratio: Gain probability vs. loss probability	1.07	1.09	-0.01
Calmar ratio: Return relative to maximum drawdown	-0.22	0.65	-0.86
Martin ratio: Return relative to average drawdown	-0.52	1.32	-1.83

CNTX vs. NVDA - Sharpe Ratio Comparison

The current CNTX Sharpe Ratio is -0.18, which is lower than the NVDA Sharpe Ratio of 0.36. The chart below compares the historical Sharpe Ratios of CNTX and NVDA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

CNTX vs. NVDA - Drawdown Comparison

The maximum CNTX drawdown since its inception was -93.53%, roughly equal to the maximum NVDA drawdown of -89.72%. Use the drawdown chart below to compare losses from any high point for CNTX and NVDA.

Drawdown Indicators

	CNTX	NVDA	Difference
Max Drawdown Largest peak-to-trough decline	-93.53%	-89.72%	-3.81%
Max Drawdown (1Y) Largest decline over 1 year	-83.51%	-20.21%	-63.30%
Max Drawdown (3Y) Largest decline over 3 years	-83.51%	-36.88%	-46.63%
Max Drawdown (5Y) Largest decline over 5 years	—	-66.34%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-66.34%	—
Current Drawdown Current decline from peak	-91.95%	-14.74%	-77.21%
Average Drawdown Average peak-to-trough decline	-79.16%	-36.07%	-43.09%
Ulcer Index Depth and duration of drawdowns from previous peaks	34.76%	9.90%	+24.86%

Volatility

CNTX vs. NVDA - Volatility Comparison

Context Therapeutics Inc. (CNTX) has a higher volatility of 25.62% compared to NVIDIA Corporation (NVDA) at 12.04%. This indicates that CNTX's price experiences larger fluctuations and is considered to be riskier than NVDA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CNTX	NVDA	Difference
Volatility (1M) Calculated over the trailing 1-month period	25.62%	12.04%	+13.58%
Volatility (6M) Calculated over the trailing 6-month period	96.67%	28.30%	+68.37%
Volatility (1Y) Calculated over the trailing 1-year period	102.24%	36.41%	+65.83%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	101.18%	51.87%	+49.31%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	101.18%	49.95%	+51.23%

Dividends

CNTX vs. NVDA - Dividend Comparison

CNTX has not paid dividends to shareholders, while NVDA's dividend yield for the trailing twelve months is around 0.14%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CNTX Context Therapeutics Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NVDA NVIDIA Corporation	0.14%	0.02%	0.03%	0.03%	0.11%	0.05%	0.12%	0.27%	0.46%	0.29%	0.45%	1.20%

Financials

Frequently Asked Questions

Can I hold both CNTX and NVDA in my portfolio?

CNTX and NVDA have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CNTX or NVDA?

CNTX has higher volatility (25.62%) compared to NVDA (12.04%). In terms of maximum drawdown, CNTX dropped -93.53% vs NVDA's -89.72%.

Which has better risk-adjusted returns?

NVDA currently has the higher Sharpe Ratio (0.36 vs -0.18), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.